HOME
>
臨床医学：外科
>
麻酔科学/ペイン
> 麻酔科医のための循環管理の実際

麻酔科医のための循環管理の実際

出版社：	中山書店
著者：	横山正尚(専門編集)
発行日：	2013-05-31
分野：	臨床医学：外科 > 麻酔科学/ペイン
ISBN：	9784521737089
シリーズ：	新戦略に基づく麻酔・周術期医学
電子書籍版：	2013-05-31 （初版第2刷）

書籍・雑誌

≪全国送料無料でお届け≫

取寄せ目安：8～14営業日

13,200 円(税込)

購入する

電子書籍

章別単位での購入はできません

ブラウザ、アプリ閲覧

13,200 円(税込)

購入する

商品紹介

麻酔科医にとって重要な周術期の循環管理に焦点を当て，術前評価，術前使用薬，麻酔薬の選択，術中のモニター，術後のリハビリなどについて，最新のエビデンスを盛り込みながら分かりやすく解説．また，周術期管理に必須の経食道心エコーやIABPの活用法なども取りあげた．アドバイス，トピックス，コラムのほか，サイドスペースに注釈も加え，現場で役立つ情報を満載した．

目次

麻酔科医のための循環管理の実際

―目次―

1章　術前の体液管理
2章　術前使用薬剤の管理
3章　合併する心疾患のリスク評価と術前準備
4章　術中輸液・輸血の考え方
5章　術中モニタリングのup-to-date
6章　麻酔方法と循環管理の考え方
7章　心血管手術の循環管理のこつ
8章　術後循環管理の実際
9章　術後痛と循環

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1章術前の体液管理

P.8 掲載の参考文献

1) American Society of Anesthesiologists Committee. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration : Application to healthy patients undergoing elective procedures : An updated report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology 2011 ; 114 : 495-511.

2) 冨田麻衣子, ほか術前絶飲食時間に関する日本の現状の再調査. 麻酔 2012 ; 61 : 643-8.

3) Brady M, et al. Preoperative fasting for adults to prevent perioperative complications. Cochrane Database Syst Rev 2003 ; 4 : CD004423.

4) Kehlet H, et al. Evidence-based surgical care and the evolution of fast track surgery. Ann Surg 2008 ; 248 : 189-98.

5) Fearon KC, et al. Enhanced recovery after surgery : A consensus review of clinical care for patients undergoing colonic resection. Clin Nutr 2005 ; 24 : 466-77.

6) 公益社団法人日本麻酔科学会. 術前絶飲食ガイドライン. 2012.

7) Ian S, et al. Perioperative fasting in adults and children : Guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiology 2011 ; 28 : 556-69.

8) Taniguchi H, et al. Preoperative fluid and electrolyte management with oral rehydration therapy. J Anesth 2009 ; 23 : 222-9.

9) Lobo DN, et al. Gastric emptying of three liquid oral preoperative metabolic preconditioning regimens measured by magnetic resonance imaging in healthy adult volunteers : A randomized double-blind, crossover study. Clin Nutr 2009 ; 28 : 636-41.

10) 桜井康良, ほか経口補水療法 (経口補水液と炭水化物負荷) の安全性の確保-非侵襲的評価法を中心にして. 麻酔 2011 ; 60 : 790-98.

11) Brady M, et al. preoperative fasting for preventing perioperative complications in children. Cochrane Database Syst Rev 2009 ; 7 : CD005285. Review.

12) American Society of Anesthesiologists task force on obstetric anesthesia. Practice guidelines for obstetric anesthesia : An update report by the American Society of Anesthesiologists task force on obstetric anesthesia. Anesthesiology 2007 ; 106 : 843-63.

13) Horowitz M, et al. Gastric emptying in diabetes : an overview. Diabet Med 1996 ; 13 : S16-22.

P.12 掲載の参考文献

1) Miller RD, ed. Miller's Anesthesia, 6th ed. Philadelphia : Elsevier, Churchill Livingstone ; 2005. 武田純三, 監修. 稲田英一, ほか監訳. ミラー麻酔科学. 原著第6版. 東京 : メディカル・サイエンス・インターナショナル ; 2007. p. 1389-414.

2) Meguid MM, et al. Complications of abdominal operations for malignant disease. Am J Surg 1988 ; 156 : 341-5.

3) Braga M, et al. ESPEN Guidelines on Parenteral Nutrition : Surgery. Clin Nutr 2009 ; 28 : 378-86.

2章術前使用薬剤の管理

P.20 掲載の参考文献

1) Mangano DT, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996 ; 335 : 1713-20.

2) Wolf A, McGoldrick KE. Cardiovascular pharmacotherapeutic considerations in patients undergoing anesthesia. Cardiol Rev 2011 ; 19 : 12-6.

3) Rosenman DJ, et al. Clinical consequences of withholding versus administering reninangiotensin-aldosterone system antagonists in the preoperative period. J Hosp Med 2008 ; 3 : 319-25.

4) Smith I, Jackson I. Beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers : Should they be stopped or not before ambulatory anaesthesia? Curr Opin Anaesthesiol 2010 ; 23 : 687-90.

5) Drenger B, et al. Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass : Effects on in-hospital morbidity and mortality. Circulation 2012 ; 126 : 261-9.

6) Eagle KA, et al. ACC/A HA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/A merican Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for N oncardiac Surgery). Circulation 2002 ; 105 : 1257-67.

7) Fleisher LA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) : Developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007 ; 116 : e418-99.

8) Fleisher LA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery : A report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation. 2009 ; 120 : e169-276.

9) Devereaux PJ, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial) : A randomised controlled trial. Lancet 2008 ; 371 : 1839-47.

10) Wallace AW, et al. Association of the pattern of use of perioperative β-blockade and postoperative mortality. Anesthesiology 2010 ; 113 : 794-805.

P.30 掲載の参考文献

1) Arepally GM, Ortel TL. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med 2006 ; 355 : 809-17.

2) Gray E, et al. Heparin and low-molecular-weight heparin. Thromb Haemost 2008 ; 99 : 807-18.

3) Turpie AGG, et al. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement. N Engl J Med 2001 ; 344 : 619-25.

4) Young G, et al. Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastography. Blood Coag Fibrinolysis 2007 ; 18 : 547-53.

5) Follis F, et al. Argatroban as a substitute of heparin during cardiopulmonary bypass : A safe alternative? Interact Cardiovasc Thorac Surg 2010 ; 10 : 592-6.

6) Connolly SJ, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009 ; 361 : 1139-51.

7) Stangier J, et al. The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects. Br J Clin Pharmacol 2007 ; 64 : 292-303.

8) Lassen MR, et al. for the RECORD3 investigators. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med 2008 ; 358 : 2776-86.

9) Eriksson BI, et al. for the RECORD1 study group. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 2008 ; 358 : 2765-75.

10) Granger CB, et al. for ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011 ; 365 : 981-92.

P.35 掲載の参考文献

1) Fleisher LA, et al. ACC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2007 ; 116 : e418-99.

2) Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery ; European Society of Cardiology (ESC), Poldermans D, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 2009 ; 30 : 2769-812.

3) Winchester DE, et al. Evience of Pre-Procedural Statin Therapy. Int J Cardiol, in press.

4) Schouten O, et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med 2009 ; 361 : 980-9.

5) Hadi HA, et al. Pleiotropic effects of statins in atrial fibrillation patients : The evidence. Vasc Health Risk Manag 2009 ; 5 : 533-51.

6) Hindler K, et al. Influence of statins on perioperative outcomes. J Cardiothorac Vasc Anesth 2006 ; 20 : 251-8.

7) Koenig MA, et al. Statin use and neurologic morbidity after coronary artery bypass grafting : A cohort study. Neurology 2009 ; 73 : 2099-106.

8) Margaritis M, et al. Statins and vein graft failure in coronary bypass graft surgery. Curr Opin Pharmacol 2012 ; 12 : 172-80.

9) Beltowski J, et al. Adverse effects of statins-mechanisms and consequences. Curr Drug Saf 2009 ; 4 : 209-28.

10) Bosch X, et al. Rhabdomyolysis and acute kidney injury. N Engl J Med 2009 ; 361 : 62-72.

11) Pineda A, et al. Statin rebound or withdrawal syndrome : Does it exist? Curr Atheroscler Rep 2011 ; 13 : 23-30.

12) Cholesterol Treatment Trialists' (CTT) Collaborators, Mihaylova B, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease : Meta-analysis of individual data from 27 randomised trials. Lancet 2012 ; 380 : 581-90.

3章合併する心疾患のリスク評価と術前準備

P.44 掲載の参考文献

1) 岩出宗代, ほか. 虚血性心疾患患者の非心臓手術の周術期管理に関する多施設共同調査第2報. 麻酔 2000 ; 49 : 796-801.

2) Munter Sellevold O, Stenseth R. Management of cardiac patients for non-cardiac surgery. Anestezjol Intens Ter 2011 ; 43 : 104-12.

3) Fleisher LA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol 2009 ; 54 : e13-118.

4) 日本循環器学会, ほか. 非心臓手術における合併心疾患の評価と管理に関するガイドライン (2008年改訂版)

5) Goldman L, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977 ; 297 : 845-50.

6) Lee TH, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999 ; 100 : 1043-9.

7) Gibbons RJ, et al. ACC/AHA guidelines for exercise testing : executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). Circulation 1997 ; 96 : 345-54.

8) 陣崎雅弘，ほか. 冠動脈CTの進歩と現状. 脈管学 2010 ; 49 : 465-72.

9) Landesberg G, et al. Preoperative thallium scanning, selective coronary revascularization and long-term survival after major vascular surgery. Circulation 2003 ; 108 : 177-83.

10) McFalls EO, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004 ; 351 : 2795-804.

P.52 掲載の参考文献

1) Stevenson LW. Tailored therapy to hemodynamic goals for advanced heart failure. Eur J Heart Fail 1999 ; 1 : 251-57.

2) American College of Cardiology Foundation American Heart Association Task Force on Practice Guidelines, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol 2009 ; 54 : e13-118.

3) 竹本恭彦, 吉川純一. 心不全の病態生理-症状から理解する. 心エコー 2005 ; 6 : 22-6.

4) Baumgartner H, et al. Echocardiographic assessment of valve stenosis : EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009 ; 22 : 1-23.

5) Zoghbi WA, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003 ; 16 : 777-802.

6) Bonow RO, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008 ; 52 : e1-142.

7) Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 2009 ; 30 : 2769-812.

P.60 掲載の参考文献

1) Brandenburg RO, et al. Report of the WHO/ISFC Task Force on the Definition and Classification of Cardiomyopathies. Br Heart J 1980 ; 44 : 672-3.

2) 北畠顕, 友池仁暢, 編. 厚生労働省難治性疾患克服研究事業特発性心筋症調査研究班心筋症診断の手引きとその解説. 2005.

3) Miura K, et al. Epidemiology of idiopathic cardiomyopathy in Japan : Results from a nationwide survey. Heart 2002 ; 87 : 126-30.

4) Koelung TM, et al. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 2002 ; 144 : 524-9.

5) Sherrid MV, et al. An echocardiographic study of the fluid mechanics of obstruction in hypertrophic cardiomyopathy. J Am Coll Cardiol 1993 ; 22 : 816-25.

6) Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995 ; 346 : 211-4.

7) 原田紳介, ほか. AHA/ACC非心臓手術のための周術期心血管系評価・管理ガイドライン 2007 : 改訂解説. 麻酔 2009 ; 58 : 228-44.

8) Thompson RC, et al. Perioperative anesthetic risk of noncardiac surgery in hypertrophic obstructive cardiomyopathy. JAMA 1985 ; 254 : 2419-21.

9) Haering JM, et al. Cardiac risk of noncardiac surgery in patients with asymmetric septal hypertrophy. Anesthesiology 1996 ; 85 : 254-9.

10) 張京浩，花岡一雄. 拡張型心筋症を合併する患者の非心臓手術の麻酔管理. 麻酔 2004 ; 53 : 1360-8.

11) 徐民恵, ほか. 重症拡張型心筋症に対する両室ペースメーカー植え込み術の麻酔経験. 日臨麻会誌 2004 ; 24 : 99-102.

12) 長谷浩吉, ほか. 拡張型心筋症の麻酔管理. 麻酔 1996 ; 45 : 741-5.

13) 張京浩, 花岡一雄. 閉塞性肥大型心筋症を合併する患者の非心臓手術の麻酔管理. 麻酔 2004 ; 53 : 934-42.

14) 竹中智昭, 野見山延. 心筋症合併例の麻酔の検討. 麻酔 1990 ; 39 : 644.

P.68 掲載の参考文献

1) Goldman L, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977 ; 297 : 845-50.

2) Forrest JB, et al. Multicenter study of general anesthesia III. Predictors of severe perioperative adverse outcomes. Anesthesiology 1992 ; 76 : 3-15.

3) Mahla E, et al. Perioperative ventricular dysrhythmias in patients with structural heart disease undergoing noncardiac surgery. Anesth Analg 1998 ; 86 : 16-21.

4) Fleisher LA, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery : Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2007 ; 116 : 1971-96.

5) Fuster V, et al ; American College of Cardiology/American Heart Association Task Force on Practice Guidelines ; European Society of Cardiology Committee for Practice Guidelines ; European Heart Rhythm Association ; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) : Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006 ; 114 : e257-354.

6) 日本循環器学会, ほか. 心房細動治療 (薬物) ガイドライン (2008年改訂版). Circ J 2008 ; Suppl IV : 1581-638.

7) Sharpe MD, et al. Sevoflurane has no effect on sinoatrial node function or normal atrioventricular and accessory pathway conduction in Wolf-Parkinson-White syndrome during alfentanil/midazolam anesthesia. Anesthesiology 1999 ; 90 : 60-5.

8) Sharpe MD, et al. Propofol has no effect on sinoatrial node function or normal atrioventricular and accessory pathway conduction in Wolf-Parkinson-White syndrome during alfentanil/midazolam anesthesia. Anesthesiology 1995 ; 82 : 888-95.

9) Kiss SJ, et al. Anesthesia for patients with congenital long QT syndrome. Anesthesiology 2005 ; 102 : 204-10.

10) Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death : A distinct clinical and electrocardiographic syndrome. A mechanism report. J Am Coll Cardiol 1992 ; 20 ; 1391-6.

11) Antzelevitch C, et al. Brugada syndrome : Report of the second consensus conference : Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005 ; 111 : 659-70.

12) Kloesel B, et al. Anesthetic management of patients with Brugada syndrome : A case series and literature review. Can J Anaesth 2011 ; 58 : 824-36.

13) Cordery R, et al. Brugada syndrome and anesthetic management. J Cardiothorac Vasc Anesth 2006 ; 20 : 407-13.

14) Junttila MJ, et al. Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias. Circulation 2008 ; 117 : 1890-3.

15) Haissaguerre M, et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med 2008 ; 358 : 2016-23.

16) Tikkanen JT, et al. Long-term outcome associated with early repolarization on electrocardiography. N Engl J Med 2009 ; 361 : 2529-37.

P.75 掲載の参考文献

1) American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Implantable Electronic Devices. Practice advisory for the perioperative management of patients with cardiac implantable electronic devices : Pacemakers and implantable cardioverter-defibrillators. Anesthesiology 2011 ; 114 : 247-61.

2) 日本循環器学会, ほか. 不整脈の非薬物治療ガイドライン 2011年改訂版. http://www.j-circ.or.jp/guideline/pdf/JCS2011_okumura_h.pdf

3) Vernooy K, et al. Relation between abnormal ventricular impulse conduction and heart failure. J Interv Cardiol 2003 ; 16 : 557-62.

4) Bernstein AD, et al. The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. North American Society of Pacing and Electrophysiology/British Pacing and Electrophysiology Group. Pacing Clin Electrophysiol 2002 ; 25 : 260-4.

5) Cleland JG, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005 ; 352 : 1539-49.

6) Linde C, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008 ; 52 : 1834-43.

7) Moss AJ, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009 ; 361 : 1329-38.

4章術中輸液・輸血の考え方

P.83 掲載の参考文献

1) Murakawa K, Kobayashi A. Effects of vasopressors on renal tissue gas tensions during hemorrhagic shock in dogs. Crit Care Med 1988 ; 16 : 789-92.

2) Lopes MR, et al. Goal-directed fluid management based on pulse pressure variation monitoring during high-risk surgery : A pilot randomized controlled trial. Crit Care 2007 ; 11 : R100.

3) Marik PE, et al. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients : A systematic review of the literature. Crit Care Med 2009 ; 37 : 2642-7.

4) Marik PE, et al. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 2008 ; 134 : 172-8.

5) Theres H, et al. Phase-related changes in right ventricular cardiac output under volume-controlled mechanical ventilation with positive end-expiratory pressure. Crit Care Med 1999 ; 27 : 953-8.

6) Cannesson M, et al. Pleth variability index to monitor the respiratory variations in the pulse oximeter plethysmographic waveform amplitude and predict fluid responsiveness in the operating theatre. Br J Anaesth 2008 ; 101 : 200-6.

7) Cannesson M, et al. Assessing the diagnostic accuracy of pulse pressure variations for the prediction of fluid responsiveness : A "gray zone" approach. Anesthesiology 2011 ; 115 : 231-41.

8) Muller L, et al. An increase in aortic blood flow after an infusion of 100 ml colloid over 1 minute can predict fluid responsiveness : The mini-fluid challenge study. Anesthesiology 2011 ; 115 : 541-7.

9) Cavallaro F, et al. Diagnostic accuracy of passive leg raising for prediction of fluid responsiveness in adults : Systematic review and meta-analysis of clinical studies. Intensive Care Med 2010 ; 36 : 1475-83.

P.90 掲載の参考文献

1) Shires T, et al. Acute change in extracellular fluids associated with major surgical procedures. Ann Surg 1961 ; 154 : 803-10.

2) Shoemaker WC, et al. Use of physiologic monitoring to predict outcome and to assist in clinical decisions in critically ill postoperative patients. Am J Surg 1983 ; 146 : 43-50.

3) Hillebrecht A, et al. Pulmonary responses to lower body negative pressure and fluid loading during head-down tilt bedrest. Acta Physiol Scand Suppl 1992 ; 604 : 35-42.

4) Nielsen OM, Engell HC. Extracellular fluid volume and distribution in relation to changes in plasma colloid osmotic pressure after major surgery. A randomized study. Acta Chir Scand 1985 ; 151 : 221-5.

5) Lobo DN, et al. How perioperative fluid balance influences postoperative outcomes. Best Pract Res Clin Anaesthesiol 2006 ; 20 : 439-55.

6) Sinclair S, et al. Intraoperative intravascular volume optimisation and length of hospital stay after repair of proximal femoral fracture : Randomised controlled trial. BMJ 1997 ; 315 : 909-12.

7) Gan TJ, et al. Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. Anesthesiology 2002 ; 97 : 820-6.

8) Cannesson M, et al. The ability to stroke volume variations obtained with Vigileo/FloTrac system to monitor fluid responsiveness in mechanically ventilated patients. Anesth Analg 2009 ; 108 : 513-7.

9) Hengy B, et al. Comparison between respiratory variations in pulse oximetry plethysmographic waveform amplitude and arterial pulse pressure during major abdominal surgery. Anesthesiology 2012 ; 117 : 973-80.

10) Donati A, et al. Goal-directed intraoperative therapy reduces moribidity and length of hospital stay in high-risk surgical patients. Chest 2007 ; 132 : 1817-24.

11) Joshi GP. Intraoperative fluid restriction improves outcome after major elective gastrointestinal surgery. Anesth Analg 2005 ; 101 : 601-5.

12) Endo A, et al. Intraoperative hydroxyethyl starch 70/0.5 is not related to acute kidney injury in surgical patients : Retrospective cohort study. Anesth Analg 2012 ; 115 : 1309-14.

P.98 掲載の参考文献

1) Peters T Jr. Historical perspective. In : All About Albumin : Biochemistry, Genetics, and Medical Applications. California : Academic Press ; 1996. p. 1-8.

2) Tanzi M, et al. Evaluation of the appropriate use of albumin in adult and pediatric patients. Am J Health Syst Pharm 2003 ; 60 : 1330-5.

3) 日本赤十字社. 輸血管理料. 輸血情報 2006 ; 0604-99.

4) Bone RC, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992 ; 101 : 1644-55.

5) Hafkenscheid JCM, et al. Measurement of the rate of synthesis of albumin with 14C-carbonate : A simplified method. Z Klin Chem Klin Biochem 1973 ; 11 : 147-51.

6) Ballmer PE, et al. Measurement of albumin synthesis in humans : A new approach employing stable isotopes. Am J Physiol 1990 ; 259 : E797-803.

7) Minghetti PP, et al. Molecular structure of the human albumin gene is revealed by nucleotide sequence within q11-22 of chromosome 4. J Biol Chem 1986 ; 261 : 6747-57.

8) Lewallen CG, et al. Studies of iodoalbumin metabolism. II. The effects of thyroid hormone. J Clin Invest 1959 ; 38 : 88-101.

9) Sterling K. The effect of Cushing's syndrome upon serum albumin metabolism. J Clin Invest 1960 ; 39 : 1900-8.

10) Gamsjager T, et al. Half-lives of albumin and cholinesterase in critically ill patients. Clin Chem Lab Med 2008 ; 46 : 1140-2.

11) Roopenian DC, Akilesh S. FcRn : The neonatal Fc receptor comes of age. Nat Rev Immunol 2007 ; 7 : 715-25.

12) Kim KJ, Malik AB. Protein transport across the lung epithelial barrier. Am J Physiol Lung Cell Mol Physiol 2003 ; 284 : L247-59.

13) Sawas AH, et al. Binding of volatile anesthetics to serum albumin : Measurements of enthalpy and solvent contributions. Biochemistry 2004 ; 43 : 12675-85.

14) Pieters BJ, et al. Inhaled anesthetics promote albumin dimerization through reciprocal exchange of subdomains. Biochem Res Int 2010 ; 2010 : 516704.

15) Ahmed N, et al. Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity. J Biol Chem 2005 ; 280 : 5724-32.

16) Cha MK, Kim IH. Disulfide between Cys392 and Cys438 of human serum albumin is redox-active, which is responsible for the thioredoxin-supported lipid peroxidase activity. Arch Biochem Biophys 2006 ; 445 : 19-25.

17) Li B, et al. Binding and hydrolysis of soman by human serum albumin. Chem Res Toxicol 2008 ; 21 : 421-31.

18) Gerasimova YV, et al. RNA-hydrolyzing activity of human serum albumin and its recombinant analogue. Bioorg Med Chem Lett 2010 ; 20 : 1427-31.

19) Yang J, et al. Structural insights into human serum albumin-mediated prostaglandin catalysis. Protein Sci 2002 ; 11 : 538-45.

20) Human albumin administration in critically ill patients : Systematic review of randomised controlled trials. Cochrane Injuries Group Albumin Reviewers. BMJ 1998 ; 317 : 235-40.

21) Vincent JL, et al. Hypoalbuminemia in acute illness : Is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 2003 ; 237 : 319-34.

22) Finfer S, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004 ; 350 : 2247-56.

23) Myburgh J, et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007 ; 357 : 874-84.

24) The Brain Trauma Foundation. American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Resuscitation of blood pressure and oxygenation. J Neurotrauma 2000 ; 17 : 471-8.

25) Cooper DJ, et al. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury : A randomized controlled trial. JAMA 2004 ; 291 : 1350-7.

26) Finfer S, et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 2011 ; 37 : 86-96.

27) Haase N, et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis : Systematic review with meta-analysis and trial sequential analysis. BMJ 2013 ; 346 : f839.

28) Dubois MJ, et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients : A prospective, randomized, controlled, pilot study. Crit Care Med 2006 ; 34 : 2536-40.

29) EudraCT number 2008-003281-25, ClinicalTrials. gov number NCT00707122.

P.106 掲載の参考文献

1) 厚生労働省医薬食品局血液対策課. 血液製剤の使用指針 (改定版). 2005年9月. p.25.

2) 日本麻酔科学会. 麻酔薬および麻酔関連薬使用ガイドライン. 第3版. VII 輸液・電解質液 http://www.anesth.or.jp/guide/pdf/publication4-7_20121106.pdf

3) Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients : Systematic review of randomized controlled trials. Br Med J 1998 ; 317 : 235-9.

4) Finfer S, et al ; The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004 ; 350 : 2247-56.

5) Brunkhorst FM, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008 ; 358 : 125-39.

6) Myburgh JA, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012 ; 397 : 1901-11.

7) Schortgen F, et al. The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 2008 ; 34 : 2157-68.

8) Perner A, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012 ; 367 : 124-34.

9) Hanart C, et al. Perioperative volume replacement in children undergoing cardiac surgery : Albumin versus hydroxyethyl starch 130/0.4. Crit Care Med 2009 ; 37 : 696-701.

10) Van Der Linden P, et al. Safety of modern starches used during surgery. Anesth Analg 2012 ; 116 : 35-48.

P.115 掲載の参考文献

1) American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies : An updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006 ; 105 : 198-208.

2) Society of Thoracic Surgeons Blood Conservation Guideline Task Force ; Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011 ; 91 : 944-82.

3) Liumbruno GM, et al. Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period. Blood Transfus 2011 ; 9 : 189-217.

4) Cabrales P, Tsai AG. Plasma viscosity regulates systemic and microvascular perfusion during acute extreme anemic conditions. Am J Physiol Heart Circ Physiol 2006 ; 291 : H2445-52.

5) 前田信治. 血液のレオロジーと生理機能 : 血液の微小循環と酸素の輸送. 日生誌 2004 ; 66 : 327-36.

6) Enriquez LJ, Shore-Lesserson L. Point-of-care coagulation testing and transfusion algorithms. Br J Anaesth 2009 ; 103 : i14-22.

7) Fouche Y, et al. Changing paradigms in surgical resuscitation. Crit Care Med 2010 ; 38 : S411-20.

8) Riskin DJ, et al. Massive transfusion protocols : The role of aggressive resuscitation versus product ratio in mortality reduction. J Am Coll Surg 2009 ; 209 : 198-205.

9) British Committee for Standards in Haematology. Guidelines on the management of massive blood loss. Br J Haematol 2006 ; 135 : 634-41.

10) Shander A, et al. Patient blood management in Europe. Br J Anaesth 2012 ; 109 : 55-68.

11) Gorlinger K, et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery : A retrospective, single-center cohort study. Anesthesiology 2011 ; 115 : 1179-91.

12) 日本輸血・細胞治療学会. 輸血副作用対応ガイド 2011. http://www.jstmct.or.jp/jstmct/Document/Guideline/Ref19-3.pdf

5章術中モニタリングの up - to - date

P.125 掲載の参考文献

1. Miller RD, et al. Miller's Anesthesia. 7th ed. Philadelphia : Elsevier, Churchill Livingstone ; 2010.

2. van Beest P, et al. Clinical review : Use of venous oxygen saturations as a goal-A yet unfinished puzzle. Crit Care 2011 ; 15 : 232.

P.134 掲載の参考文献

1) 渡橋和政. 経食道心エコー法マニュアル. 第4版. 東京 : 南江堂 ; 2012.

2) Shanewise JS, et al. ASE/SCA guidelines for performing a comprehensive intraoperative multiplane transesophageal echocardiography examination : Recommendations of the American Society of Echocardiography Council for Intraoperative Echocardiography and the Society of Cardiovascular Anesthesiologists Task Force for Certification in Perioperative Transesophageal Echocardiography. J Am Soc Echocardiogr 1999 ; 12 : 884-900.

3) Orihashi K, et al. Intraoperative occlusion of left coronary ostium after aortic repair detected by transesophageal echocardiography. J Thorac Cardiovasc Surg 2011 ; 142 : e205-6.

4) Orihashi K. Intraoperative imaging in aortic valve surgery as a safety net. In : Motomura N, ed. Aortic Valve Surgery. Croatia : InTech ; 2011. p. 3-18.

P.142 掲載の参考文献

1) Swan HJ, et al. Catheterization of the heart in man with use of a flow-directed balloontipped catheter. N Engl J Med 1970 ; 283 : 447-51.

2) Shah KB, et al. A review of pulmonary artery catheterization in 6,245 patients. Anesthesiology 1984 ; 61 : 271-5.

3) Domino KB, et al. Injuries and liability related to central vascular catheters : A closed claims analysis. Anesthesiology 2004 ; 100 : 1411-8.

4) Shoemaker WC, et al. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988 ; 94 : 1176-86.

5) Gattinoni A, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 1995 ; 333 : 1025-32.

6) Connors AF Jr, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigations. JAMA 1996 ; 276 : 889-97.

7) Ramsey SD, et al. Clinical and economic effects of pulmonary artery catheterization in nonemergent coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2000 ; 14 : 113-8.

8) Sandham JD, et al. A randomized, controlled trial of the use of pulmonary artery catheters in high-risk surgical patients. N Engl J Med 2003 ; 348 : 5-14.

9) Harvey S, et al. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man) : A randomized controlled trial. Lancet 2005 ; 366 : 472-7.

10) Binanay C, et al. ESCAPE Investigators and ESCAPE Study Coordinators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness : The ESCAPE trial. JAMA 2005 ; 294 : 1625-33.

11) National Heart Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network ; Wheeler AP, et al. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 2006 ; 354 : 2213-24.

12) 大西佳彦. 肺動脈カテーテル. 麻酔 2009 ; 58 : 884-90.

13) 鈴木利保, ほか. PAC (肺動脈カテーテル) から忠実な波形を得るために. 麻酔・集中治療とテクノロジー 1993 ; 1 : 22-5.

14) 鈴木利保, ほか. 肺動脈カテーテルの周波数特性の改善法について. 循環制御 1997 ; 18 : 242-51.

15) Renner LE, et al. Indicator amount, temperature, and intrinsic cardiac output affect thermodilution cardiac output accuracy and reproducibility. Crit Care Med 1993 ; 21 : 586-97.

16) Konishi T, et al. Comparison of thermodilution and Fick methods for measurement of cardiac output in tricuspid regurgitation. Am J Cardiol 1992 ; 70 : 538-9.

17) 鈴木利保. 非心臓手術におけるCCO (連続心拍出量) 測定の意義と有用性, Anet 2006 ; 10 : 16-21.

18) Gettinger A, et al. In vivo comparison of two mixed venous saturation catheters. Anesthesiology 1987 ; 66 : 373-5.

19) Reinhart K, Bloos F. The value of venous oximetry. Curr Opin Crit Care 2005 ; 11 : 259-63.

20) Rivers E, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001 ; 345 : 1368-77.

21) 鈴木利保. 穿刺器材からみた血管穿刺の安全性. LISA 2006 ; 13 : 1094-100.

22) Suzuki T, et al. An improved puncture-insertion kit for a Swan-Ganz catheter. Circulation Control 1996 ; 17 : 543-6.

23) 鈴木利保, ほか. Swan-Ganz カテーテル挿入の長さおよび留置したカテーテル先端の移動-挿入部位による相違の比較検討. 循環制御 1990 ; 11 : 485-8.

24) Barash PG, et al. Catheter induced pulmonary artery perforation. Mechanisms, management, and modifications. J Thorac Cardiovasc Surg 1981 ; 82 : 5-12.

25) Johnston WE, et al. Pulmonary artery catheter migration during cardiac surgery. Anesthesiology 1986 ; 64 : 258-62.

26) Maki DG, et al. A prospective randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters implications for catheter management. Crit Care Med 1994 ; 22 : 1729-37.

27) Randolph AG, et al. Benefit of heparin in central venous and pulmonary artery catheters : A meta-analysis of randomized controlled trials. Chest 1998 ; 113 : 165-71.

28) Wiener RS, Welch HG. Trends in the use of the pulmonary artery catheter in the United States, 1993-2004. JAMA 2007 ; 298 : 423-9.

29) Chatterjee K. The Swan-Ganz catheters : Past, present, and future. A viewpoint. Circulation 2009 ; 119 : 147-52.

30) Pinsky MR, Vincent JL. Let us use the pulmonary artery catheter correctly and only when we need it. Crit Care Med 2005 ; 33 : 1119-22.

31) American Society of Anesthesiologists Task Force on Pulmonary Artery Catheterization. Practice guidelines for pulmonary artery catheterization : An updated report by the American Society of Anesthesiologists Task Force on Pulmonary Artery Catheterization. Anesthesiology 2003 ; 99 : 988-1014.

32) Rubenfeld GD, et al. The pulmonary artery catheter, 1967-2007 : Rest in Peace? JAMA 2007 ; 298 : 458-61.

33) Ospina-Tascon GA, et al. What type of monitoring has been shown to improve outcomes in acutely ill patients? Intensive Care Med 2008 ; 34 : 800-20.

34) 池崎弘之, 川村豪嗣. スワンガンツカテーテルの功罪. 日臨麻会誌 2011 ; 31 : 67-73.

P.152 掲載の参考文献

1) Bland RD, et al. Hemodynamic and oxygen transport patterns in surviving and nonsurviving postoperative patients. Crit Care Med 1985 ; 13 : 85-90.

2) Shoemaker WC, et al. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988 ; 94 : 1176-86.

3) Rivers E, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001 ; 345 : 1368-77.

4) Dellinger RP, et al. Surviving Sepsis Campaign : International guidelines for management of severe sepsis and septic shock : 2008. Crit Care Med 2008 ; 36 : 296-327.

5) Vincent JL, et al. Sepsis in European intensive care units : Results of the SOAP study. Crit Care Med 2006 ; 34 : 344-53.

6) Antonelli M, et al. Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27-28 April 2006. Intensive Care Med 2007 ; 33 : 575-90.

7) Lakhal K, et al. Tracking hypotension and dynamic changes in arterial blood pressure with brachial cuff measurements. Anesth Analg 2009 ; 109 : 494-501.

8) Dunser MW, et al. Arterial blood pressure during early sepsis and outcome. Intensive Care Med 2009 ; 35 : 1225-33.

9) Watanabe H, et al. The discrepancy between invasive and noninvasive blood pressure. Sapp Med J 1990 ; 59 : 111-7.

10) Burchell SA, et al. Evaluation of a continuous cardiac output and mixed venous oxygen saturation catheter in critically ill surgical patients. Crit Care Med 1997 ; 25 : 388-91.

11) Gattinoni L, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995 ; 333 : 1025-32.

12) Pargger H, et al. Gastric intramucosal pH-guided therapy in patients after elective repair of infrarenal abdominal aneurysms : Is it beneficial? Intensive Care Med 1998 ; 24 : 769-76.

13) Lichtwarck-Aschoff M, et al. Intrathoracic blood volume accurately reflects circulatory volume status in critically ill patients with mechanical ventilation. Intensive Care Med 1992 ; 18 : 142-7.

14) Sakka SG, et al. Assessment of cardiac preload and extravascular lung water by single transpulmonary thermodilution. Intensive Care Med 2000 ; 26 : 180-7.

15) Cannesson M, et al. Pleth variability index to monitor the respiratory variations in the pulse oximeter plethysmographic waveform amplitude and predict fluid re spon siveness in the operating theatre. Br J Anaesth 2008 ; 101 : 200-6.

16) Cannesson M, et al. Respiratory variations in pulse oximetry plethysmographic waveform amplitude to predict fluid responsiveness in the operating room. Anesthesiology 2007 ; 106 : 1105-11.

17) Forget P, et al. Goal-directed fluid management based on the pulse oximeter-derived pleth variability index reduces lactate levels and improves fluid management. Anesth Analg 2010 ; 111 : 910-4.

18) Yamada T, et al. Multicenter study verifying a method of noninvasive continuous cardiac output measurement using pulse wave transit time : A comparison with intermittent bolus thermodilution cardiac output. Anesth Analg 2012 ; 115 : 82-7.

19) Ishihara H, et al. The ability of a new continuous cardiac output monitor to measure trends in cardiac output following implementation of a patient information calibration and an automated exclusion algorithm. J Clin Monit Comput 2012 ; 26 : 465-71.

6章麻酔方法と循環管理の考え方

P.161 掲載の参考文献

1) Ghoneim MM, Block RI. Clinical, methodological and theoretical issues in the assessment of cognition after anaesthesia and surgery : A review. Eur J Anaesthesiol 2012 ; 29 : 409-22.

2) Selnes OA, et al. Cognitive and neurologic outcomes after coronary-artery bypass surgery. N Engl J Med 2012 ; 366 : 250-7.

3) Rivera R, Antognini JF. Perioperative drug therapy in elderly patients. Anesthesiology 2009 ; 110 : 1176-81.

4) Prough DS. Anesthetic pitfalls in the elderly patient. J Am Coll Surg 2005 ; 200 : 784-94.

5) Jani B, Rajkumar C. Ageing and vascular ageing. Postgrad Med J 2006 ; 82 : 357-62.

6) Brandes RP, et al. Endothelial aging. Cardiovasc Res 2005 ; 66 : 286-94.

7) Rooke GA. Cardiovascular aging and anesthetic implications. J Cardiothorac Vasc Anesth 2003 ; 17 : 512-23.

8) Lakatta EG. Alterations in the cardiovascular system that occur in advanced age. Fed Proc 1979 ; 38 : 163-7.

9) Priebe HJ. The aged cardiovascular risk patient. Br J Anaesth 2000 ; 85 : 763-78.

10) Vuyk J. Pharmacodynamics in the elderly. Best Pract Res Clin Anaesthesiol 2003 ; 17 : 207-18.

11) Aymanns C, et al. Review on pharmacokinetics and pharmacodynamics and the aging kidney. Clin J Am Soc Nephrol 2010 ; 5 : 314-27.

12) Fleisher LA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery : A report of the American College Of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2007 ; 50 : e159-241.

13) Kersten JR, et al. Isoflurane mimics ischemic preconditioning via activation of K (ATP) channels : Reduction of myocardial infarct size with an acute memory phase. Anesthesiology 1997 ; 87 : 361-70.

14) Cope DK, et al. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology 1997 ; 86 : 699-709.

15) Belhomme D, et al. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999 ; 100 : ii340-4.

16) Landoni G, et al. Halogenated anaesthetics and cardiac protection in cardiac and noncardiac anaesthesia. Ann Card Anaesth 2009 ; 12 : 4-9.

17) Kin H, et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 2004 ; 62 : 74-85.

18) Tritapepe L, et al. Cardiac protection by volatile anaesthetics : A multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Eur J Anaesthesiol 2007 ; 24 : 323-31.

19) Guarracino F, et al. Myocardial damage prevented by volatile anesthetics : A multicenter randomized controlled study. J Cardiothorac Vasc Anesth 2006 ; 20 : 477-83.

20) De Hert SG, et al. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 2004 ; 101 : 9-20.

21) De Hert SG, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004 ; 101 : 299-310.

22) De Hert SG, et al. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology 2003 ; 99 : 314-23.

23) De Hert SG, et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002 ; 97 : 42-9.

24) Tuman KJ, et al. Does choice of anesthetic agent significantly affect outcome after coronary artery surgery? Anesthesiology 1989 ; 70 : 189-98

25) Seccareccia F, et al. The Italian CABG Outcome Study : Short-term outcomes in patients with coronary artery bypass graft surgery. Eur J Cardiothorac Surg 2006 ; 29 : 56-62 ; discussion 62-4.

26) Landoni G, et al. Desflurane and sevoflurane in cardiac surgery : A meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 2007 ; 21 : 502-11.

27) Cromheecke S, et al. Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass. Anesth Analg 2006 ; 103 : 289-96.

28) Fochi O, et al. Cardiac protection by volatile anesthetics in non-cardiac surgery : A meta-analysis. Minerva Anestesiol 2007 ; 73 : 26.

29) Landoni G, et al. Cardioprotection by volatile anesthetics in noncardiac surgery? No, not yet at least. J Am Coll Cardiol 2008 ; 51 : 1321 ; author reply 1321-2.

30) Ovize M, et al. Postconditioning and protection from reperfusion injury : Where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 2010 ; 87 : 406-23.

31) Hausenloy DJ, et al. Translating novel strategies for cardioprotection : The Hatter Workshop Recommendations. Basic Res Cardiol 2010 ; 105 : 677-86.

32) Sun Q, et al. Hydrogen-rich saline protects myocardium against ischemia/reperfusion injury in rats. Exp Biol Med 2009 ; 234 : 1212-9.

33) Hayashida K, et al. Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun 2008 ; 373 : 30-5.

34) Yoshida A, et al. H (2) mediates cardioprotection via involvements of K (ATP) channels and permeability transition pores of mitochondria in dogs. Cardiovasc Drugs Ther 2012 ; 26 : 217-26.

35) Hausenloy DJ, et al. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol 2009 ; 104 : 189-202.

36) Di Lisa F, et al. Mitochondrial injury and protection in ischemic pre-and postconditioning. Antioxid Redox Signal 2011 ; 14 : 881-91.

37) Heusch G, et al. Inhibition of mitochondrial permeability transition pore opening : The Holy Grail of cardioprotection. Basic Res Cardiol 2010 ; 105 : 151-4.

P.173 掲載の参考文献

1) Rodgers A, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia : Results from overview of randomised trials. BMJ 2000 ; 321 : 1493.

2) Richman JM, et al. Does continuous peripheral nerve block provide superior pain control to opioids? A meta-analysis. Anesth Analg 2006 ; 102 : 248-57.

3) Wulf H, et al. Ropivacaine epidural anesthesia and analgesia versus general anesthesia and intravenous patient-controlled analgesia with morphine in the perioperative management of hip replacement. Ropivacaine Hip Replacement Multicenter Study Group. Anesth Analg 1999 ; 89 : 111-6.

4) Mann C, et al. Comparison of intravenous or epidural patient-controlled analgesia in the elderly after major abdominal surgery. Anesthesiology 2000 ; 92 : 433-41.

5) van Lier F, et al. Epidural analgesia is associated with improved health outcomes of surgical patients with chronic obstructive pulmonary disease. Anesthesiology 2011 ; 115 : 315-21.

6) Beattie WS, et al. Epidural analgesia reduces postoperative myocardial infarction : A meta-analysis. Anesth Analg 2001 ; 93 : 853-8.

7) Casati A, et al. Randomized comparison between sevoflurane anaesthesia and unilateral spinal anaesthesia in elderly patients undergoing orthopaedic surgery. Eur J Anaesthesiol 2003 ; 20 : 640-6.

8) Mauermann WJ, et al. A comparison of neuraxial block versus general anesthesia for elective total hip replacement : A meta-analysis. Anesth Analg 2006 ; 103 : 1018-25.

9) Jorgensen LN, et al. Antithrombotic efficacy of continuous extradural analgesia after knee replacement. Br J Anaesth 1991 ; 66 : 8-12.

10) Martin F, et al. Antiinflammatory effect of peripheral nerve blocks after knee surgery : Clinical and biologic evaluation. Anesthesiology 2008 ; 109 : 484-90.

11) Gottschalk A, et al. Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology 2010 ; 113 : 27-34.

12) Werawatganon T, Charuluxanun S. Patient controlled intravenous opioid analgesia versus continuous epidural analgesia for pain after intra-abdominal surgery. Cochrane Database Syst Rev 2005 ; (1) : CD004088.

13) Brull R, et al. Neurological complications after regional anesthesia : Contemporary estimates of risk. Anesth Analg 2007 ; 104 : 965-74.

14) Horlocker TT, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy : American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med 2010 ; 35 : 64-101.

15) Neal JM, et al. ASRA practice advisory on local anesthetic systemic toxicity. Reg Anesth Pain Med 2010 ; 35 : 152-6 1.

16) Muraskin SI, et al. Falls associated with lower-extremity-nerve blocks : A pilot investigation of mechanisms. Reg Anesth Pain Med 2007 ; 32 : 67-72.

17) Shah JL. Lesson of the week : Postoperative pressure sores after epidural anaesthesia. BMJ 2000 ; 321 : 941-2.

18) Introna R, et al. Sympathovagal effects of spinal anesthesia assessed by heart rate variability analysis. Anesth Analg 1995 ; 80 : 315-21.

19) Tanaka M, et al. The effects of cervical and lumbar epidural anesthesia on heart rate variability and spontaneous sequence baroreflex sensitivity. Anesth Analg 2004 ; 99 : 924-9.

P.184 掲載の参考文献

1) Kato T, et al. The effect of fentanyl on sevoflurane requirements for somatic and sympathetic responses to surgical incision. Anesthesiology 1999 ; 90 : 398-405.

2) Sebel PS, et al. Reduction of the MAC of desflurane with fentanyl. Anesthesiology 1992 ; 76 : 52-9.

3) Daniel M, et al. Fentanyl augments the blockade of the sympathetic response to incision (MAC-BAR) produced by desflurane and isoflurane : Desflurane and isoflurane MAC-BAR without and with fentanyl. Anesthesiology 1998 ; 88 : 43-9.

4) Inagaki Y, et al. Segmental analgesic effect and reduction of halothane MAC from epidural fentanyl in humans. Anesth Analg 1992 ; 74 : 856-64.

5) Inagaki Y, et al. The effects of epidural fentanyl on hemodynamic responses during emergence from isoflurane anesthesia and tracheal extubation : A comparison with intravenous fentanyl. Anesth Analg 1997 ; 85 : 328-35.

6) Kazama T, et al. The pharmacodynamic interaction between propofol and fentanyl with respect to the suppression of somatic or hemodynamic responses to skin incision, peritoneum incision, and abdominal wall retraction. Anesthesiology 1998 ; 89 : 894-906.

7) Lang E, et al. Reduction of isoflurane minimal alveolar concentration by remifentanil. Anesthesiology 1996 ; 85 : 721-8.

8) Manyam SC, et al. Opioid-volatile anesthetic synergy : A response surface model with remifentanil and sevoflurane as prototypes. Anesthesiology 2006 ; 105 : 267-78.

9) Dedola E, et al. Effect of nitrous oxide on desflurane MACBAR at two targetcontrolled concentrations of remifentanil. Minerva Anesthesiol 2008 ; 74 : 165-72.

10) Kern SE, et al. A response analysis of propofol-remifentanil pharmacodynamic interaction in volunteers. Anesthesiology 2004 ; 100 : 1373-81.

11) Milne SE, et al. Propofol sparing effect of remifentanil using closed-loop anaesthesia. Br J Anaesth 2003 ; 90 : 623-9.

12) Inagaki Y, et al. Time-related differential effects of epidural morphine on the neuraxis. Anesth Analg 1993 ; 76 : 308-15.

13) Ishiyama T, et al. Epidural ropivacaine anesthesia decreases the bispectral index during the awake phase and sevofluranegeneral anesthesia. Anesth Analg 2005 ; 100 : 728-32.

14) Hodgson PS, Liu SS. Epidural lidocaine decreases sevoflurane requirement for adequate depth of anesthesia as measured by the Bispectral Index monitor. Anesthesiology 2001 ; 94 : 799-803.

P.194 掲載の参考文献

1) Nielsen DV, et al. Variation in use of peroperative inotropic support therapy in cardiac surgery : Time for reflection? Acta Anaesthesiol Scand 2011 ; 55 : 352-8.

2) Hoffman BB, Taylor P. Neurotransmission : The autonomic and somatic motor nervous systems. In : Gilman AG, et al, eds. Goodman and Gilman's the Pharmacological Basis of Therapeutics. 10th ed. New York : McGraw-Hill ; 2001. p. 115-53.

3) Overgaard CB, Dzavik V. Inotropes and vasopressors : Review of physiology and clinical use in cardiovascular disease. Circulation 2008 ; 118 : 1047-56.

4) Hollenberg SM. Vasoactive drugs in circulatory shock. Am J Respir Crit Care Med 2011 ; 183 : 847-55.

5) Giamouzis G, et al. Impact of dopamine infusion on renal function in hospitalized heart failure patients : Results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial. J Card Fail 2010 ; 16 : 922-30.

6) De Backer D, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010 ; 362 : 779-89.

7) Fellahi JL, et al. Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome : Propensity-adjusted analyses. Anesthesiology 2008 ; 108 : 979-87.

8) Veeser M, et al. Vasopressors for the management of hypotension after spinal anesthesia for elective caesarean section. Systematic review and cumulative meta-analysis. Acta Anaesthesiol Scand 2012 ; 56 : 810-6.

9) Baruch L, et al. Pharmacodynamic effects of milrinone with and without a bolus loading infusion. Am Heart J 2001 ; 141 : 266-73.

10) Poldermans D, et al. Perioperative strokes and beta-blockade. Anesthesiology 2009 ; 111 : 940-5.

11) Sezai A, et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting : New evidence from the PASCAL trial. J Thorac Cardiovasc Surg 2011 ; 141 : 1478-87.

12) Russell JA, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008 ; 358 : 877-87.

7章心血管手術の循環管理のコツ

P.203 掲載の参考文献

1) Kobayashi J, et al. Early outcome of a randomized comparison of off-pump and onpump multiple arterial coronary revascularization. Circulation 2005 ; 112 (9 suppl) : I338-43.

2) Murzi M, et al. On-pump and off-pump coronary artery bypass grafting in patients with left main stem disease : A propensity score analysis. J Thorac Cardiovasc Surg 2012 ; 143 : 1382-8.

3) Saleh HZ, et al. Does avoidance of cardiopulmonary bypass confer any benefits in octogenarians undergoing coronary surgery? Interact Cardiovasc Thorac Surg 2011 ; 12 : 435-9.

4) Darwazah AK, et al. Off-pump coronary artery bypass in multi-vessel disease : Effect of ejection fraction on early and midterm mortality and morbidity. J Cardiovasc Surg 2008 ; 49 : 519-26.

5) Liu JF, et al. Outcome of off-pump coronary artery bypass in renal dialysis patients. Thorac Cardiovasc Surg 2008 ; 56 : 412-7.

6) Miyazaki S, et al. Risk factors of stroke and delirium after off-pump coronary artery bypass surgery. Interact Cardiovasc Thorac Surg 2011 ; 12 : 379-83.

7) Dyub AM, et al. Preoperative intra-aortic balloon pump in patients undergoing coronary bypass surgery : A systematic review and meta-analysis. J Card Surg 2008 ; 23 : 79-86.

8) Gurbuz AT, et al. Intraoperative transesophageal echocardiography modifies strategy in off-pump coronary artery bypass grafting. Ann Thorac Surg 2007 ; 83 : 1035-40.

P.213 掲載の参考文献

1) Seltzer JL, Gerson JI. Decrease in arterial pressure following heparin injection prior to cardiopulmonary bypass. Acta Anaesthesiol Scand 1979 ; 23 : 575-8.

2) Urban P, et al. The hemodynamic effects of heparin and their relation to ionized calcium levels. J Thorac Cardiovasc Surg 1986 ; 91 : 303-6.

3) Wu W, et al. Vasopressin release during cardiac operation. J Thorac Cardiovasc Surg 1980 ; 79 : 83-90.

4) Thrush DN, et al. Cardiopulmonary bypass temperature does not affect postoperative euthyroid sick syndrome? Chest 1995 ; 108 : 1541-5.

5) Lacoumenta S, et al. Hormonal and metabolic responses to cardiac surgery with sufentanil-oxygen anaesthesia. Acta Anaesthesiol Scand 1987 ; 31 : 258-63.

6) Diedericks BJ, et al. The renin-angiotensin-aldosterone system during and after cardiopulmonary bypass. S Afr Med J 1983 ; 64 : 946-9.

7) Nagaoka H, et al. Preservation of pancreatic beta cell function with pulsatile cardiopulmonary bypass. Ann Thorac Surg 1989 ; 48 : 798-802.

8) Curello S, et al. Time course of human atrial natriuretic factor release during cardiopulmonary bypass in mitral valve and coronary artery diseased patients. Eur J Cardiothorac Surg 1991 ; 5 : 205-10.

9) Barr G, et al. Fentanyl and midazolam anaesthesia for coronary bypass surgery : A clinical study of bispectral electroencephalogram analysis, drug concentrations and recall. Br J Anaesth 2000 ; 84 : 749-52.

10) Abel RM, et al. Etiology, incidence and prognosis of renal failure following cardiac operations. Results of a prospective analysis of 500 consecutive patients. J Thorac Cardiovasc Surg 1976 ; 71 : 323-33.

11) 吉田和則, ほか. 僧帽弁狭窄症に対する人工弁置換術. LiSA 2008 ; 15 : 400-9.

12) Mangano DT. Biventricular function after myocardial revascularization in humans : Deterioration and recovery patterns during the first 24 hours. Anesthesiology 1985 ; 62 : 571-7.

P.220 掲載の参考文献

1) Kirno K, et al. Thoracic epidural anesthesia during coronary artery bypass surgery : Effects on cardiac sympathetic activity, myocardial blood flow and metabolism, and central hemodynamics. Anesth Analg 1994 ; 79 : 1075-81.

2) Kazama T, et al. The pharmacodynamics interaction between propofol and fentanyl with respect to the suppression of somatic or hemodynamic responses to skin incision, peritoneum incision, and abdominal wall retraction. Anesthesiology 1998 ; 89 : 894-906.

3) Colson P, et al. Renin angiotensin system antagonists and anesthesia. Anesth Analg 1999 ; 89 : 1143-55.

4) Katoh T, et al. Sevoflurane requirements for tracheal intubation with and without fentanyl. Br J Anaesth 1999 ; 82 : 561-5.

5) Albertin A, et al. The effect-site concentration of remifentanil blunting cardiovascular responses to tracheal intubation and skin incision during bispectral index-guided propofol anesthesia. Anesth Analg 2005 ; 101 : 125-30.

6) 中垣俊明, ほか. セボフルラン麻酔導入における気管挿管時循環変動に対するレミフェンタニル投与時間の影響. 麻酔 2009 ; 58 : 713-8.

7) Griepp RE, Griepp EB. Spinal cord perfusion and protection during descending thoracic and thoracoabdominal aortic surgery : The collateral network concept. Ann Thorac Surg 2007 ; 83 : S865-9.

8) Johnston KW. Multicenter prospective study of nonruptured abdominal aortic aneurysm. Part II. Variables predicting morbidity and mortality. J Vasc Surg 1989 ; 9 : 437-47.

9) Gamulin Z, et al. Effect of infrarenal aortic cross-clamping on renal hemodynamics in humans. Anesthesiology 1984 ; 61 : 394-9.

10) Hayashi Y, et al. Synthetic human alpha-atrial natriuretic peptide improves the management of postoperative hypertension and renal dysfunction after the repair of abdominal aortic aneurysm. J Cardiovasc Pharmacol 2003 ; 42 : 636-41.

P.230 掲載の参考文献

1) Robicsek F. Robotic cardiac surgery : Time told ! J Thorac Cardiovasc Surg 2008 ; 135 : 243-6.

2) Woo YJ, Nacke EA. Robotic minimally invasive mitral valve reconstruction yields less blood product transfusion and shorter length of stay. Surgery 2006 ; 140 : 263-7.

3) Suri RM, et al. Quality of life after early mitral valve repair using conventional and robotic approaches. Ann Thorac Surg 2012 ; 93 : 761-9.

4) Wimmer-Greinecker G, et al. Totally endoscopic atrial septal repair in adults with computer-enhanced telemanipulation. J Thorac Cardiovasc Surg 2003 ; 126 : 465-8.

5) Argenziano M, et al. Totally endoscopic atrial septal defect repair with robotic assistance. Circulation 2003 ; 108 (Suppl 1) : II191-4.

6) Masroor S, et al. Complex repair of a Barlow's valve using the Da Vinci robotic surgical system. J Heart Valve Dis 2010 ; 19 : 593-5.

7) Gao C, et al. Robotically assisted mitral valve replacement. J Thorac Cardiovasc Surg 2012 ; 143 : S64-7.

8章術後循環管理の実際

P.241 掲載の参考文献

1) Hofer CK, et al. Stroke volume and pulse pressure variation for prediction of fluid responsiveness in patients undergoing off-pump coronary artery bypass grafting. Chest 2005 ; 128 : 848-54.

2) Perel A, et al. Systolic blood pressure variation is a sensitive indicator of hypovolemia in ventilated dogs subjected to graded hemorrhage. Anesthesiology 1987 ; 67 : 498-502.

3) Biais M, et al. Case scenario : Respiratory variations in arterial pressure for guiding fluid management in mechanically ventilated patients. Anesthesiology 2012 ; 116 : 1354-61.

4) Cannesson M, et al. Assessing the diagnostic accuracy of pulse pressure variations for the prediction of fluid responsiveness : A "gray zone" approach. Anesthesiology 2011 ; 115 : 231-41.

5) Marik PE, et al. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients : A systematic review of the literature. Crit Care Med 2009 ; 37 : 2642-7.

6) Michard F, et al. Pulse pressure variation : Beyond the fluid management of patients with shock. Crit Care 2007 ; 11 : 131-3.

7) Marik PE, et al. Hemodynamic parameters to guide fluid therapy. Ann Intensive Care 2011 ; 1 : 1.

8) Nouira S, et al. Effects of norepinephrine on static and dynamic preload indicators in experimental hemorrhagic shock. Crit Care Med 2005 ; 33 : 2339-43.

9) Ozaki M, et al. Pulse oximeter-based flow index correlates well with fingertip volume plethysmography. Anesthesiology 1993 ; 79 : A542.

10) Shepherd SJ, et al. Role of central and mixed venous oxygen saturation measurement in perioperative care. Anesthesiology 2009 ; 111 : 649-56.

11) Collaborative Study Group on Perioperative ScvO2 Monitoring. Multicentre study on peri- and postoperative central venous oxygen saturation in high-risk surgical patients. Crit Care 2006 ; 10 : R158.

12) Donati A et al. Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk surgical patients. Chest 2007 ; 132 : 1817-24

13) Rivers E, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001 ; 345 : 1368-77.

14) Rhodes A et al. Early goal-directed therapy : An evidence-based review. Crit Care Med 2004 ; 32 (11 suppl) : S448-50

15) Pinsky MR, et al. Let us use the pulmonary artery catheter correctly and only when we need it. Crit Care Med 2005 ; 33 : 1119-22.

P.252 掲載の参考文献

1) Kircher BJ, et al. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 1990 ; 66 : 493-6.

2) Orihashi K, et al. Left in tern al thoracic artery graft assessed by means of intraoperative transesophageal echocardiography. Ann Thorac Surg 2005 ; 79 : 580-4.

3) Orihashi K, et al. Intraoperative assessment of coronary bypass graft to posterior descending artery by means of transesophageal echocardiography. Interact Cardiovasc Thorac Surg 2009 ; 8 : 507-11.

P.258 掲載の参考文献

1) Walsh SR, et al. Postoperative arrhythmias in general surgical patients. Ann R Coll Surg Engl 2007 ; 89 : 91-5.

2) Almassi GH, et al. Atrial fibrillation after cardiac surgery : A major morbid event? Ann Surg 1997 ; 226 : 501-11.

3) Walsh SR, et al. Postoperative arrhythmias in colorectal surgical patients : Incidence and clinical correlates. Colorectal Dis 2006 ; 8 : 212-6.

4) Bagshaw SM, et al. Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery : A meta-analysis. Ann Thorac Surg 2006 ; 82 : 1927-37.

5) Mitchell LB, et al. Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair : PAP ABEAR : A randomized controlled trial. JAMA 2005 ; 294 : 3093-100.

6) Sakamoto A, et al. Landiolol, an ultra-short-acting β1-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery : Prospective, multicenter, randomized, open-label study (JL-KNIGHT study). Circ J 2012 ; 76 : 1097-101.

P.265 掲載の参考文献

1) Henderson WR, et al. Clinical review : Guyton-the role of mean circulatory filling pressure and right atrial pressure in controlling cardiac output. Crit Care 2010 ; 14 : 243.

2) West JB, et al. Distribution of blood flow in isolated lung ; relation to vascular and alveolar pressures. J Appl Physiol 1964 ; 19 : 713-24.

3) Luecke T, et al. Assessment of cardiac preload and left ventricular function under increasing levels of positive end-expiratory pressure. Intensive Care Med 2004 ; 30 : 119-26.

4) Marik PE, et al. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 2008 ; 134 : 172-8.

5) Fessler HE, et al. Effects of positive end-expiratory pressure and body position on pressure in the thoracic great veins. Am Rev Respir Dis 1993 ; 148 : 1657-64.

6) Michard F, et al. Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med 2000 ; 162 : 134-8.

7) Michard F, Teboul JL. Using heart-lung interactions to assess fluid responsiveness during mechanical ventilation. Crit Care 2000 ; 4 : 282-9.

8) Kim HK, Pinsky MR. Effect of tidal volume, sampling duration, and cardiac contractility on pulse pressure and stroke volume variation during positive-pressure ventilation. Crit Care Med 2008 ; 36 : 2858-62.

P.272 掲載の参考文献

1) 日本循環器学会ほか. 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告) 急性心不全治療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_izumi_h.pdf

2) 日本循環器学会ほか. 循環器病の診断と治療に関するガイドライン (2007年度合同研究班報告) 非心臓手術における合併心疾患の評価と管理に関するガイドライン (2008年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2008_kyo_h.pdf

3) Yoshitani H, et al. Effects of intra-aortic balloon counterpulsation on coronary pressure in patients with stenotic coronary arteries. Am Heart J 2007 ; 154 : 725-31.

4) Santa-Cruz RA, et al. Aortic counterpulsation : A review of the hemodynamic effects and indications for use. Catheter Cardiovasc Interv 2006 ; 67 : 68-77.

5) Thiele H, et al. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCKII) trial. Am Heart J 2012 ; 163 : 938-45.

6) Trost JC, Hillis LD. Intra-aortic balloon counterpulsation. Am J Cardiol 2006 ; 97 : 1391-8.

P.279 掲載の参考文献

1) 澤芳樹, ほか. PCPSの概要. 松田輝, 監修. 経皮的心肺補助法-PCPSの最前線. 東京 : 秀潤社 ; 2004. p.9-12.

2) PCPS研究会. 全国集計調査結果 2003-2005. 2005. www2.convention.co.jp/pcps/

3) Rastan AJ, et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg 2010 ; 139 : 302-11.

4) Naidu SS. Novel percutaenous cardiac assist devices : The science of and indications for hemodynamic support. Circulation 2011 ; 123 : 533-43.

5) Hayashi Y, et al. Percutaneous cardiopulmonary support with heparin-coated circuits in postcardiotomy cardiogenic shock. Efficacy and comparison with left heart bypass. Jpn J Thorac Cardiovasc Surg 2000 ; 48 : 274-9.

6) 田口眞一, 四津良平. 開心術後の応用. 松田輝, 監修. 経皮的心肺補助法-PCPSの最前線. 東京 : 秀潤社 ; 2004. p.125-31.

7) 澤芳樹. PCPSの現況と展望. Clinical Engineering 2011 ; 22 : 523-9.

8) Allen S, et al. A review of the fundamental principles and evidence base in the use of extracorporeal membrane oxygenation (ECMO) in critically ill adult patients. J Intensive Care Med 2011 ; 26 : 13-26.

9) Smedira NG, et al. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure : Survival at five years. J Thorac Cardiovasc Surg 2001 ; 122 : 92-102.

10) Saito S, et al. Is extracorporeal life support contraindicated in elderly patients? Ann Thorac Surg 2007 ; 83 : 140-5.

11) 浅井康文, ほか. PCPSの適応, 適応除外と治療の実際. Clinical Engineering 2011 ; 22 : 530-5.

12) 西村元延. PCPS施行に際しての実際. 松田輝, 監修. 経皮的心肺補助法-PCPSの最前線. 東京 : 秀潤社 ; 2004. p.133-9.

13) Koizumi K, et al. A case in which biventricular assist device support was required after aortic valve replacement with a bioprosthetic valve. J Artif Organs 2003 ; 6 : 218-21.

14) Swartz MT, et al. Ventricular assist device support in patients with mechanical heart valves. Ann Thorac Surg 1999 ; 68 : 2248-51.

15) 澤芳樹. PCPSの外科基準. 松田輝, 監修. 経皮的心肺補助法-PCPSの最前線. 東京 : 秀潤社 ; 2004. p.17-22.

16) 田鎖治ほか経皮的心肺補助装置から補助人工心臓への移行. 松田輝, 監修. 経皮的心肺補助法-PCPSの最前線. 東京 : 秀潤社 ; 2004. p. 133-9.

17) Fiser SM, et al. When to discontinue extracorporeal membrane oxygenation for postcardiotomy support. Ann Thorac Surg 2001 ; 71 : 210-4.

18) Wu MY, et al. Postcardiotomy extracorporeal life support in adults : The optimal duration of bridging to recovery. ASAIO J 2009 ; 55 : 608-13.

19) Doll N, et al. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg 2004 ; 77 : 151-7.

20) Unosawa S, et al. Long-term outcomes of patients undergoing extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. Surg Today 2012 ; 43 : 264-70.

21) 許俊鋭. 経皮的補助循環-過去・現在・未来. Clinical Enginieering 2011 ; 22 : 507-12.

P.286 掲載の参考文献

1) 日本循環器学会. 循環器病の診断と治療に関するガイドライン合同研究班. 心血管疾患におけるリハビリテーションに関するガイドライン (2012年改訂版). http://square.umin.ac.jp/jacr/link/doc/JCS2012_nohara_h.pdf

2) Cruz-Jentoft AJ, et al. Sarcopenia : European consensus on definition and diagnosis. Age Ageing 2010 ; 39 : 412-23.

3) 若林秀隆. 低栄養への対応. 月刊薬事 2011 ; 53 : 39-43.

4) 平澤博之. ICU患者の長期転帰. ICUとCCU 2012 ; 36 : 391-7.

5) 曷川元. リハビリテーション-重症患者特有の筋力低下ICU-AW. 重症集中ケア 2011 ; 11 : 64-9.

6) 池崎弘之, ほか. 心臓手術の麻酔方法. 日臨麻会誌 2009 ; 29 : 132-42.

7) 外須美夫. 呼吸・循環のダイナミズム. 東京 : 真興交易医書出版部 ; 2001. p. 278-9.

8) Ali J, et al. Consequences of postoperative alterations in respiratory mechanics. Am J Surg 1974 ; 128 : 376-82.

9) Agostoni E, Mead J. Statics of the respiratory system. In : Fenn WO, Rahn H, eds. Handbook of Physiology. Washington DC : American Physiological Society ; 1964. p. 387-409.

10) Gattinoni L, et al. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 2001 ; 345 : 568-73.

11) Kopterides P, et al. Prone positioning in hypoxemic respiratory failure : Meta-analysis of randomized controlled trials. J Crit Care 2009 ; 24 : 89-100.

12) Mounier R, et al. Study of prone positioning to reduce ventilator-associated pneumonia in hypoxaemic patients. Eur Respir J 2010 ; 35 : 795-804.

13) Albert RK, Hubmayr RD. The prone position eliminates compression of the lungs by the heart. Am J Respir Crit Care Med 2000 ; 161 : 1660-5.

14) 日本循環器学会. 循環器病の診断と治療に関するガイドライン合同研究班. 心血管疾患におけるリハビリテーションに関するガイドライン (2012年改訂版). p.43. http://square.umin.ac.jp/jacr/link/doc/JCS2012_nohara_h.pdf

15) Cotton P. Fast track improves CABG outcomes. JAMA 1993 ; 270 : 2023.

16) 南淵明宏. 心臓外科におけるfast track recovery. Heart View 1999 ; 3 : 1166-72.

17) Riker RR, et al. 重症患者の鎮静におけるデクスメデトミジンとミダゾラムの比較. JAMA 2009 日本語版別刷 ; 301 : 489-99.

18) Schweickert WD, Kress JP. Implementing early mobilization interventions in mechanically ventilated patients in the ICU. Chest 2011 ; 140 : 1612-7.

19) Pohlman MC, et al. Feasibility of physical and occupational therapy begining from initiation of mechanical ventilation. Crit Care Med 2010 ; 38 : 2089-94.

20) Thomsen GE, et al. Patients with respiratory failure increase ambulation after transfer to an intensive care unit where early activity is a priority. Crit Care Med 2008 ; 36 : 1119-24.

21) Schweickert WD, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients : A randomised controlled trial. Lancet 2009 ; 373 : 1874-82.

22) 飯田有輝, 坪内宏樹. ICU患者の早期能動運動療法の効果. ICUとCCU 2012 ; 36 : 407-13.

23) 熊丸めぐみ, ほか. 心臓血管外科手術後のリハビリテーション遅延例の検討. 心臓リハビリテーション2002 ; 7 : 109-12.

24) Auer J, et al. Antiarrhythmic therapy on prevention of postoperative atrial fibrillation in patients after heart surgery. Curr Med Chem Cardiovasc Hematol Agents 2004 ; 2 : 29-34.

25) De Jonghe B, et al. Paresis acquired in intensive care unit : A prospective multicenter study. JAMA 2002 ; 288 : 2859-67.

9章術後痛と循環

P.293 掲載の参考文献

1) Liu S, et al. Epidural anesthesia and analgesia : Their role in postoperative outcome. Anesthesiology 1995 ; 82 : 1474-506.

2) Desborough JP. The stress response to trauma and surgery. Br J Anaesth 2000 ; 85 : 109-17.

3) Mangano DT, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996 ; 335 : 1713-20.

4) Wijeysundera DN, et al. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications : A meta-analysis. Am J Med 2003 ; 114 : 742-52.

5) Bent JM, et al. Effect of high-dose fentanyl anaesthesia on the established metabolic and endocrine response to surgery. Anaesthesia 1984 ; 39 : 19-23.

6) Liu SS, Wu CL. Effect of postoperative analgesia on major postoperative complications : A systemic update of the evidence. Anesth Analg 2007 ; 104 : 689-702.

P.299 掲載の参考文献

1) Hepner DL, Castells MC. Anaphylaxis during the perioperative period. Anesth Analg 2003 ; 97 : 1381-95.

2) Hollenberg SM, Dellinger RP. Noncardiac surgery : Postoperative arrhythmias. Crit Care Med 2000 ; 28 : N145-50.

3) Nicholau D. The postanesthesia care unit. In : Miller RD, ed. Miller's Anesthesia. 7th ed. Philadelphia : Churchill Livingstone ; 2009. p.2719.

4) Ebert TJ, et al. Sympathetic responses to induction of anesthesia in humans with propofol or etomidate. Anesthesiology 1992 ; 76 : 725-33.

5) Chang KS, Davis RF. Propofol produces endothelium-independent vasodilation and may act as a Ca2+ channel blocker. Anesth Analg 1993 ; 76 : 24-32.

6) Yamashita A, et al. Inhibitory effects of propofol on acetylcholine-induced, endothelium-dependent relaxation and prostacyclin synthesis in rabbit mesenteric resistance arteries. Anesthesiology 1999 ; 91 : 1080-9.

7) Pagel PS, Warltier DC. Negative inotropic effects of propofol as evaluated by the regional preload recruitable stroke work relationship in chronically instrumented dogs. Anesthesiology 1993 ; 78 : 100-8.

8) Sharpe MD, et al. Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia. Anesthesiology 1995 ; 82 : 888-95.

9) Sunzel M, et al. Respiratory and cardiovascular effects in relation to plasma levels of midazolam and diazepam. Br J Clin Pharmacol 1988 ; 25 : 561-9.

10) Sakamoto M, et al. Effects of midazolam and flumazenil on carotid sinus baroreflex control of circulation in rabbits. Br J Anaesth 1994 ; 73 : 384-7.

11) Tomicheck RC, et al. Diazepam-fentanyl interaction -hemodynamic and hormonal effects in coronary artery surgery. Anesth Analg 1983 ; 62 : 881-4.

12) Dyck JB, et al. The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 1993 ; 78 : 813-20.

13) Ebert TJ, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000 ; 93 : 382-94.

14) Saeki T, et al. Electrophysiological demonstration and activation of mu-opioid receptors in the rabbit sinoatrial node. J Cardiovasc Pharmacol 1995 ; 26 : 160-8.

15) Stefano GB. Autoimmunovascular regulation : Morphine and anandamide and ancondamide stimulated nitric oxide release. J Neuroimmunol 1998 ; 83 : 70-6.

16) Zola EM, McLeod DC. Comparative effects and analgesic efficacy of the agonistantagonist opioids. Drug Intell Clin Pharm 1983 ; 17 : 411-7.

17) Yu Y, et al. Vascular COX-2 modulates blood pressure and thrombosis in mice. Sci Transl Med 2012 ; 4 : 132ra54.

18) Rygnestad T, et al. Postoperative epidural infusion of morphine and bupivacaine is safe on surgical wards. Organisation of the treatment, effects and side-effects in 2,000 consecutive patients. Acta Anaesthesiol Scand 1997 ; 41 : 868-76.

19) Burstal R, et al. Epidural analgesia : Prospective audit of 1062 patients. Anaesth Intensive Care 1998 ; 26 : 165-72.

20) Liu SS, et al. Patient-controlled epidural analgesia with bupivacaine and fentanyl on hospital wards : Prospective experience with 1,030 surgical patients. Anesthesiology 1998 ; 88 : 688-95.

21) Wigfull J, Welchew E. Survey of 1,057 patients receiving postoperative patientcontrolled epidural analgesia. Anaesthesia 2001 ; 56 : 70-5.

22) Wheatley RG, et al. Safety and efficacy of postoperative epidural analgesia. Br J Anaesth 2001 ; 87 : 47-61.

23) Davies RG, et al. A comparison of the analgesic efficacy and side-effects of paravertebral vs epidural blockade for thoracotomy -a systematic review and metaanalysis of randomized trials. Br J Anaesth 2006 ; 96 : 418-26.

24) Whitaker EE, et al. Severe hypotension after interscalene block for outpatient shoulder surgery : A case report. J Clin Anesth 2010 ; 22 : 132-4.

書評

書評を投稿する

最近チェックした商品履歴

Loading...